Canlyniadau Chwilio - Emilio A. Emini

Mireinio'r Canlyniadau
  1. 1
    Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization

    Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization gan Emilio A. Emini, Philomena Ostapchuk, Eckard Wimmer

    Cyhoeddwyd 1983
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C

    Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C gan S Pincus, David C. Diamond, Emilio A. Emini, Eckard Wimmer

    Cyhoeddwyd 1986
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

    Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide gan Emilio A. Emini, J V Hughes, Debra S. Perlow, Joshua Boger

    Cyhoeddwyd 1985
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    A novel assay for the DNA strand-transfer reaction of HIV-1 integrase

    A novel assay for the DNA strand-transfer reaction of HIV-1 integrase gan Daria J. Hazuda, Jeffrey C. Hastings, Abigail Wolfe, Emilio A. Emini

    Cyhoeddwyd 1994
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies

    Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies gan Emilio A. Emini, S Y Kao, Angela Lewis, R Crainic, Eckard Wimmer

    Cyhoeddwyd 1983
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies

    Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies gan Emilio A. Emini, Bradford A. Jameson, Angela Lewis, G R Larsen, Eckard Wimmer

    Cyhoeddwyd 1982
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy

    Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy gan Jon H. Condra, Christos J. Petropoulos, Rainer Ziermann, William A. Schleif, Malathi Shivaprakash, Emilio A. Emini

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

    Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody gan Miroslaw K. Górny, Alan J. Conley, S Karwowska, Aby Buchbinder, Jiake Xu, Emilio A. Emini, Scott Koenig, Susan Zolla‐Pazner

    Cyhoeddwyd 1992
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

    Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. gan Alan J. Conley, Joseph Kessler, L J Boots, J S Tung, Beth Arnold, Paul M. Keller, Alan Shaw, Emilio A. Emini

    Cyhoeddwyd 1994
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors

    Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors gan Jon H. Condra, Emilio A. Emini, L Gotlib, Donald J. Graham, A J Schlabach, Jill Wolfgang, Richard J. Colonno, Vinod Sardana

    Cyhoeddwyd 1992
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Active human immunodeficiency virus protease is required for viral infectivity.

    Active human immunodeficiency virus protease is required for viral infectivity. gan Nancy E. Kohl, Emilio A. Emini, William A. Schleif, Lenora J. Davis, Jill C. Heimbach, Richard A. Dixon, Edward M. Scolnick, Irving S. Sigal

    Cyhoeddwyd 1988
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.

    Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors. gan Vinod Sardana, Emilio A. Emini, L Gotlib, Donald J. Graham, D W Lineberger, William J. Long, A J Schlabach, Jill Wolfgang, Jon H. Condra

    Cyhoeddwyd 1992
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure

    Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure gan Joseph K. Wong, Huldrych F. Günthard, Diane V. Havlir, Zhi‐Qiang Zhang, Ashley T. Haase, Caroline Ignacio, Shirley Kwok, Emilio A. Emini, Douglas D. Richman

    Cyhoeddwyd 1997
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

    Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors gan Jack H. Nunberg, William A. Schleif, Evelyn Boots, J A O'Brien, J C Quintero, J. M. HOFFMAN, Emilio A. Emini, Mark E. Goldman

    Cyhoeddwyd 1991
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

    Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells gan Robert L. LaFemina, Christine L. Schneider, Helen L. Robbins, P L Callahan, K LeGrow, E. Jill Roth, William A. Schleif, Emilio A. Emini

    Cyhoeddwyd 1992
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada

    Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada gan Otto G. Vanderkooi, David W. Scheifele, Douglas Girgenti, Scott A. Halperin, Scott D. Patterson, William C. Gruber, Emilio A. Emini, Daniel A. Scott, James D. Kellner

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

    Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees gan Emilio A. Emini, Peter L. Nara, William A. Schleif, John A. Lewis, J P Davide, D R Lee, Joseph Kessler, S Conley, Shuzo Matsushita, Scott D. Putney

    Cyhoeddwyd 1990
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

    Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D gan Alan J. Conley, Miroslaw K. Górny, Joseph Kessler, L J Boots, M Ossorio-Castro, Scott Koenig, D W Lineberger, Emilio A. Emini, Constance Williams, Susan Zolla‐Pazner

    Cyhoeddwyd 1994
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine gan Lisa A. Jackson, Alejandra Gurtman, Kathryn Rice, Karlis Pauksens, Richard N. Greenberg, Thomas R. Jones, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults gan Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff, Kathrin U. Jansen, Deepthi Jayawardene, Carmel Devlin, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: